Dopamine pills are supplements or drugs used to increase dopamine levels or activity in the brain. They are not made of dopamine itself, since this neurochemical is not effective when administered orally.
Natural dopamine is synthesized inside the brain – and it cannot cross the blood brain barrier (BBB) if taken in pill form. This means that if you were to take a pill that contained dopamine, it would not have any effects on mood, movement, cognitive function, focus and more.
However, there are other supplements and medications that work by boosting levels of dopamine in the brain or by mimicking some of its effects. By increasing the availability of certain dopamine precursors, it is possible to positively affect mood, mental drive and concentration.
What are the best dopamine-boosting pills to take, how do they work and are they safe? In this article, we will look at the effects of L-DOPA, Phenylalanine, Tyrosine and Mucuna Pruriens supplements.



- Supports energy & motivation
- Promotes focus & mental clarity
- Improves mood & stress response
Dopamine Synthesis
Related Topics
The precursors of dopamine (C8H11NO2) are: L-phenylalanine (C9H11NO2), L-tyrosine (C9H11NO3) and L-DOPA (C9H11NO4).
Many of the most popular dopamine-boosting pills available contain these compounds, or derivatives/combinations of them.
The process of dopamine biosynthesis begins by taking in foods that contain the essential amino acid phenylalanine. Humans cannot synthesize phenylalanine de novo, which means that we have to eat food sources of it.
Some of the best foods for this include lean meats, eggs, green leafy vegetables, chicken and liver.
The L isomer of phenylalanine is then converted to a nonessential, DNA-encoded amino acid called L-tyrosine. This conversion occurs via the actions of an enzyme called phenylalanine hydroxylase; one of a class of aromatic amino acid hydroxylases abbreviated AAAH.
L-tyrosine is then converted to natural L-DOPA via the actions of another aromatic amino acid hydroxylase enzyme called tyrosine hydroxylase.
The L isomer of DOPA serves as a precursor for dopamine and other catecholamine neurotransmitters including norepinephrine (noradrenaline) and epinephrine (adrenaline).
L-DOPA travels across the BBB to be converted into dopamine via an aromatic L-amino acid decarboxylase enzyme called dopa decarboxylase.
To recap, the dopamine biosynthesis pathway can be viewed as: L-phenylalanine get converted to L-tyrosine, which gets converted to L-DOPA, which gets converted to Dopamine
Dopamine Pill Ingredients
Even though you cannot take actual dopamine pills to raise levels of this brain chemical, you can use other natural supplements to indirectly increase the synthesis of dopamine in the brain.
L-phenylalanine and L-tyrosine supplements are two of the most commonly used options. Many people are confused about which of these works better for increasing dopamine in the brain.
Both are capable of inducing mood-enhancing effects. Both are able to stimulate/modulate control over catecholamine neurotransmitters like dopamine, but their metabolic pathways are slightly different.
In a safety comparison study, L-tyrosine seemed to offer the better option. L-tyrosine breaks down faster in the blood.
Although this means less actually makes it across the BBB into the brain, there is also less chance for overdose or adverse side effects. In daily doses raging between 500 mg and 5 g, L-tyrosine demonstrates high tolerability and very few side effects.
L-phenylalanine stays in the blood longer than L-tyrosine before breaking down. It is far more likely to reach toxic accumulations than L-tyrosine.
L-phenylalanine is associated with adverse effects including anxiety, panic attacks, sleep disruptions, heart palpitations and poor digestion. It is not recommended as a first choice dopamine-increasing pill.
Another popular option is N-Acetyl L-Tyrosine (NALT), which is a more bio-available form of L-tyrosine. However, there is conflicting research available regarding how much NALT is converted into dopamine after oral administration.
L-DOPA Pills
In medical contexts, you will commonly see medicines that contain L-DOPA used to treat dopamine deficiency, particularly when caused by Parkinson’s disease. The medication Levodopa is the most widely used.
Chemically, Levodopa is the same L-3,4-dihydroxyphenylalanine molecule as L-DOPA. However, L-DOPA and Levodopa are not quite the same.
L-DOPA refers to the natural chemical precursor for dopamine and other monoamine/catecholamine neurotransmitters. It is manufactured in the body.
Levodopa is a synthetic version of L-DOPA, made in laboratories and used primarily as a first-choice treatment for Parkinson’s disease.
Levodopa is a dopamine pill that was introduced in the 1960s. It is absorbed into the circulatory system inside the small intestines, and then travels to the brain to produce dopamine.
Levodopa is almost always administered in combination with Carbidopa; a Levodopa enhancer that enables up to 80% lower doses of Levodopa to be used therapeutically.
L-DOPA Side Effects
Common side effects of Levodopa include nausea and vomiting. Other possible adverse effects of Levodopa include low blood pressure (hypotension), heart arrhythmias, gastrointestinal bleeding, decreased libido (sex drive) and extreme emotional states.
Other possible adverse effects include hallucinations, narcolepsy and decreased capacities for learning.
Using Levodopa chronically for Parkinson’s disease treatment can cause even more serious side effects. Some of these include freezing during movement, tardive dyskinesia (involuntary movement), inability to move with intention, resistance to other dopaminergic drugs and dopamine dysregulation syndrome.
Despite the adverse effects associated with Levodopa dopamine pills, they are still considered to be safer overall than other anti-Parkinson’s agents, like dopamine receptor agonists and anticholinergics. Levodopa drugs are prescription only.
Mucuna Pruriens for Boosting Dopamine
There are natural sources of L-DOPA that can be used as dietary supplements.
Mucuna pruriens is a plant more commonly called velvet beans. It contains roughly 5% natural L-DOPA.
Some users prefer mucuna extract as a dopamine-boosting agent because it works faster than L-Tyrosine. Whereas the conversion of tyrosine to dopamine is rate-limited in the body, the conversion of L-DOPA to dopamine happens much faster.
This means that mucuna pruriens supplements may have a more immediate effect on raising dopamine levels. This is both good and bad: in some cases, it may work better than other natural dopamine sources, but it may also have a heightened risk of side effects.
However, it is generally well tolerated when used appropriately. In one large, double blind study, human subjects were given between 15 and 30 g of M. pruriens daily for between 12 and 20 weeks. Aside from a singular case of vomiting, no adverse effects were noted.
Conclusions
Which is the best dopamine-increasing pill to use? There has been relatively little research on mucuna extract, which is why L-tyrosine and L-phenylalanine are more commonly purchased by supplement users.
L-tyrosine is rated as likely safe when used appropriately in amounts commonly found in the diet. Tyrosine is possibly safe for up to 3 months, without adverse effects, at doses as high as 150 mg daily.
Powdered formulations of Mucuna pruriens are rated as possibly safe, which used orally and appropriately. Hairs from M. pruriens bean pods are rated as possibly unsafe and may cause severe itching, inflammation and/or burning.
Neither L-tyrosine or Mucuna pruriens supplements have been studied enough to determine their safety for pregnant or nursing women. Usage in these groups is not recommended.
Before taking dopamine pills to increase levels of this neurotransmitter, it is best to seek medical advice – particularly if using these supplements for a specific medical condition.
Dopamine boosters can interact with different medicines, herbs and dietary supplements. They may also be contraindicated for use in individuals with pre-existing medical conditions.
- Wing VC1, Payer DE2, Houle S3, George TP4, Boileau I2. Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study. Neuropsychopharmacology. 2015 May;40(6):1417-27. doi: 10.1038/npp.2014.327. Epub 2014 Dec 15.
- Kempster PA1, Gibb WR, Stern GM, Lees AJ. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):72-6.
- Lou HC1. Dopamine precursors and brain function in phenylalanine hydroxylase deficiency. Acta Paediatr Suppl. 1994 Dec;407:86-8.
- Lucia Raffaella Lampariello,1 Alessio Cortelazzo,2 Roberto Guerranti,2 Claudia Sticozzi,3 and Giuseppe Valacchi3,4,* The Magic Velvet Bean of Mucuna pruriens Journal ListJ Tradit Complement Medv.2(4); Oct-Dec 2012PMC3942911
- Yokogoshi H1, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998 May;23(5):667-73.
- Janssen PA1, Leysen JE, Megens AA, Awouters FH. Does phenylethylamine act as an endogenous amphetamine in some patients? Int J Neuropsychopharmacol. 1999 Sep;2(3):229-240.
- Jiang H1, Wang J2, Rogers J3, Xie J4. Brain Iron Metabolism Dysfunction in Parkinson's Disease. Mol Neurobiol. 2016 Apr 2. [Epub ahead of print]
- Arnsten AF1, Girgis RR2, Gray DL3, Mailman RB4. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia. Biol Psychiatry. 2016 Jan 18. pii: S0006-3223(16)00044-5. doi: 10.1016/j.biopsych.2015.12.028. [Epub ahead of print]
- Arnsten AF1, Wang M2, Paspalas CD2. Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders. Pharmacol Rev. 2015 Jul;67(3):681-96. doi: 10.1124/pr.115.010512.
- Torres-Courchoud I1, Chen HH. Is there still a role for low-dose dopamine use in acute heart failure? Curr Opin Crit Care. 2014 Oct;20(5):467-71. doi: 10.1097/MCC.0000000000000133.
- Hu H1. Reward and Aversion. Annu Rev Neurosci. 2016 Apr 21. [Epub ahead of print]
- Solinas M1, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci. 2002 Aug 1;22(15):6321-4.
- Volkow ND1, Wang GJ1, Logan J2, Alexoff D2, Fowler JS2, Thanos PK2, Wong C1, Casado V3, Ferre S4, Tomasi D1. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Transl Psychiatry. 2015 Apr 14;5:e549. doi: 10.1038/tp.2015.46.
- Salinas AG1, Davis MI2, Lovinger DM2, Mateo Y3. Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum. Neuropharmacology. 2016 Mar 29. pii: S0028-3908(16)30121-6. doi: 10.1016/j.neuropharm.2016.03.049. [Epub ahead of print]
- Field T1, Hernandez-Reif M, Diego M, Schanberg S, Kuhn C. Cortisol decreases and serotonin and dopamine increase following massage therapy. Int J Neurosci. 2005 Oct;115(10):1397-413.
- Fernstrom JD1, Fernstrom MH Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr. 2007 Jun;137(6 Suppl 1):1539S-1547S; discussion 1548S.
- Liju, Vijayastelter B., Kottarapat Jeena, and Ramadasan Kuttan. "An Evaluation of Antioxidant, Anti-Inflammatory, and Antinociceptive Activities of Essential Oil from Curcuma Longa. L." Indian Journal of Pharmacology 43.5 (2011): 526–531. PMC. Web. 7 Apr. 2016.
Article last updated on: July 6th, 2018 by Nootriment